Valuation: B.R.A.I.N. Biotechnology Research and Information Network AG

Market Cap 63.79M 72.97M 58.63M 54.65M 104M 6.95B 105M 704M 274M 3.42B 274M 268M 11.77B P/E 2026 *
-7.72x
P/E 2027 * -12.2x
Enterprise Value 86.2M 98.61M 79.22M 73.84M 140M 9.39B 142M 951M 370M 4.62B 370M 362M 15.9B EV / Sales 2026 *
1.61x
EV / Sales 2027 * 1.46x
Free-Float
41.64%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: B.R.A.I.N. Biotechnology Research and Information Network AG

Manager TitleAgeSince
Chief Executive Officer 62 01/02/2020
Director of Finance/CFO 56 01/10/2022
Chief Tech/Sci/R&D Officer 40 01/01/2023
Director TitleAgeSince
Chairman 65 08/03/2023
Director/Board Member 61 14/10/2020
Director/Board Member 62 08/03/2023
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 72.97M
+1.24%-3.41%-50.91%-79.97% 213M
-0.56%-0.84%+290.35%+544.93% 153M
-0.53%+6.42%+7.22%-49.64% 84.23M
Average +0.04%+0.72%+82.22%+138.44% 149.93M
Weighted average by Cap. +0.25%-0.69%+76.10%+138.34%

Financials

2026 *2027 *
Net sales 53.57M 61.27M 49.23M 45.88M 87.03M 5.83B 88.35M 591M 230M 2.87B 230M 225M 9.88B 62.66M 71.67M 57.58M 53.67M 102M 6.82B 103M 691M 269M 3.35B 269M 263M 11.56B
Net income -8.24M -9.43M -7.58M -7.06M -13.39M -898M -13.6M -90.94M -35.35M -441M -35.39M -34.63M -1.52B -5.23M -5.98M -4.81M -4.48M -8.5M -570M -8.63M -57.7M -22.43M -280M -22.46M -21.97M -965M
Net Debt 22.41M 25.63M 20.59M 19.19M 36.41M 2.44B 36.96M 247M 96.1M 1.2B 96.21M 94.15M 4.13B 27.4M 31.34M 25.18M 23.47M 44.52M 2.98B 45.19M 302M 118M 1.47B 118M 115M 5.05B
Logo B.R.A.I.N. Biotechnology Research and Information Network AG
BRAIN Biotech AG, is formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG, is a Germany -based Company. The Company is a supplier of bio-based products and solutions such as enzymes and proteins, microbial production strains, natural substances, and biotechnological solutions for industrial processes in the areas of nutrition, health, and the environment. BRAIN Biotech is also offers contract research and development in the fields of enzyme technology, microbial strain development and bioprocess development.
Employees
280
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-